Umer Raffat
Stock Analyst at Evercore ISI
(3.90)
# 1,820
Out of 4,371 analysts
161
Total ratings
47.9%
Success rate
7.8%
Average return
Main Sectors:
Stocks Rated by Umer Raffat
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| SYRE Spyre Therapeutics | Maintained: Buy | n/a | $78.48 | - | 6 | Jun 3, 2026 | |
| PCVX Vaxcyte | Maintained: Buy | n/a | $48.76 | - | 2 | May 21, 2026 | |
| BIIB Biogen | Initiated Coverage: Buy | n/a | $196.45 | - | 8 | May 15, 2026 | |
| KLRA Kailera Therapeutics | Initiated Coverage: Buy | n/a | $20.99 | - | 1 | May 12, 2026 | |
| ELAN Elanco Animal Health | Maintained: Buy | n/a | $24.71 | - | 6 | May 11, 2026 | |
| GILD Gilead Sciences | Maintained: Buy | n/a | $129.18 | - | 15 | May 7, 2026 | |
| LLY Eli Lilly and Company | Maintained: Hold | n/a | $1,125.27 | - | 13 | May 4, 2026 | |
| AMGN Amgen | Maintained: Buy | n/a | $345.60 | - | 17 | May 1, 2026 | |
| TSX: BHC Bausch Health Companies Inc. | Maintained: Hold | n/a | $7.31 | - | 6 | Apr 30, 2026 | |
| PFE Pfizer | Maintained: Buy | n/a | $25.69 | - | 8 | Apr 27, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $39.80 | - | 3 | Apr 20, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $13.40 | - | 7 | Apr 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $34.16 | - | 3 | Mar 27, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $10 | $4.42 | +126.24% | 3 | Mar 9, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $55.02 | - | 3 | Feb 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $34.43 | - | 9 | Nov 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $43.38 | - | 6 | Nov 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $25.05 | - | 2 | Nov 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $24.69 | - | 6 | Oct 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $0.7336 | - | 2 | Sep 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $14.32 | n/a | 3 | May 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $9.25 | n/a | 1 | Feb 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $120.26 | n/a | 3 | Feb 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | n/a | $15.35 | n/a | 1 | Oct 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $14.31 | n/a | 4 | Mar 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | n/a | $9.86 | n/a | 5 | May 11, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | n/a | $34.20 | n/a | 1 | Nov 1, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $15.90 | n/a | 6 | Dec 9, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $240.06 | n/a | 5 | Jan 28, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $114.82 | n/a | 3 | Jul 20, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $4.25 | n/a | 2 | Jun 4, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | n/a | $16.57 | n/a | 1 | Mar 9, 2018 |
Spyre Therapeutics
Jun 3, 2026
Maintained: Buy
Price Target: n/a
Current: $78.48
Upside: -
Vaxcyte
May 21, 2026
Maintained: Buy
Price Target: n/a
Current: $48.76
Upside: -
Biogen
May 15, 2026
Initiated Coverage: Buy
Price Target: n/a
Current: $196.45
Upside: -
Kailera Therapeutics
May 12, 2026
Initiated Coverage: Buy
Price Target: n/a
Current: $20.99
Upside: -
Elanco Animal Health
May 11, 2026
Maintained: Buy
Price Target: n/a
Current: $24.71
Upside: -
Gilead Sciences
May 7, 2026
Maintained: Buy
Price Target: n/a
Current: $129.18
Upside: -
Eli Lilly and Company
May 4, 2026
Maintained: Hold
Price Target: n/a
Current: $1,125.27
Upside: -
Amgen
May 1, 2026
Maintained: Buy
Price Target: n/a
Current: $345.60
Upside: -
Bausch Health Companies Inc.
Apr 30, 2026
Maintained: Hold
Price Target: n/a
Current: $7.31
Upside: -
Pfizer
Apr 27, 2026
Maintained: Buy
Price Target: n/a
Current: $25.69
Upside: -
Apr 20, 2026
Maintained: Buy
Price Target: n/a
Current: $39.80
Upside: -
Apr 10, 2026
Maintained: Hold
Price Target: n/a
Current: $13.40
Upside: -
Mar 27, 2026
Maintained: Buy
Price Target: n/a
Current: $34.16
Upside: -
Mar 9, 2026
Maintained: Buy
Price Target: $10
Current: $4.42
Upside: +126.24%
Feb 12, 2026
Maintained: Hold
Price Target: n/a
Current: $55.02
Upside: -
Nov 26, 2025
Maintained: Buy
Price Target: n/a
Current: $34.43
Upside: -
Nov 12, 2025
Maintained: Buy
Price Target: n/a
Current: $43.38
Upside: -
Nov 11, 2025
Maintained: Buy
Price Target: n/a
Current: $25.05
Upside: -
Oct 8, 2025
Maintained: Buy
Price Target: n/a
Current: $24.69
Upside: -
Sep 30, 2025
Maintained: Buy
Price Target: n/a
Current: $0.7336
Upside: -
May 12, 2025
Maintained: Buy
Price Target: n/a
Current: $14.32
Upside: n/a
Feb 21, 2025
Maintained: Buy
Price Target: n/a
Current: $9.25
Upside: n/a
Feb 5, 2025
Maintained: Buy
Price Target: n/a
Current: $120.26
Upside: n/a
Oct 15, 2024
Upgraded: Buy
Price Target: n/a
Current: $15.35
Upside: n/a
Mar 8, 2024
Downgraded: Hold
Price Target: n/a
Current: $14.31
Upside: n/a
May 11, 2023
Upgraded: Buy
Price Target: n/a
Current: $9.86
Upside: n/a
Nov 1, 2022
Initiated Coverage: Buy
Price Target: n/a
Current: $34.20
Upside: n/a
Dec 9, 2021
Maintained: Buy
Price Target: n/a
Current: $15.90
Upside: n/a
Jan 28, 2021
Maintained: Buy
Price Target: n/a
Current: $240.06
Upside: n/a
Jul 20, 2020
Reiterated: Buy
Price Target: n/a
Current: $114.82
Upside: n/a
Jun 4, 2019
Maintained: Buy
Price Target: n/a
Current: $4.25
Upside: n/a
Mar 9, 2018
Initiated Coverage: Buy
Price Target: n/a
Current: $16.57
Upside: n/a